|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Carl T. Hayden VA Medical Center
* To whom correspondence should be addressed. E-mail: Christian.Meyer{at}va.gov.
We examined the intracellular metabolic fate of plasma glucose during a hyperglycemic clamp in impaired glucose tolerant (IGT; N=21) and normal glucose tolerant subjects (N=10) using a combination of [3-3H] glucose infusion with measurement of [3H] water formation and indirect calorimetry. IGT was associated with ~35% reduced first phase insulin responses, normal second phase insulin response and 25-30% reduced insulin sensitivity, resulting in ~35% reduced plasma glucose disposal. This was coupled with ~55% reduced storage of plasma glucose (P<0.01) and ~15-20% reduced glycolysis of plasma glucose (P<0.03), accounting for ~75 and 25% of the reduction in glucose disposal, respectively. Decreased glucose oxidation accounted for virtually all the decrease in glycolysis. Therefore, non-oxidative glycolysis of plasma glucose in IGT was similar to that in NGT (P>0.9) and accounted for an increased proportion of systemic glucose disposal (p<0.05). We conclude that in IGT, decreased disposal of plasma glucose mainly involves decreased glycogen synthesis and to a lesser extent decreased glycolysis, which is accounted for by decreased glucose oxidation. An increased proportion of plasma glucose hence undergoes non-oxidative glycolysis, representing a novel early abnormality in the pathogenesis of T2DM.
This article has been cited by other articles:
![]() |
E. L. Dillon and M. Sheffield-Moore Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes: Response to Davidson Diabetes Care, July 1, 2009; 32(7): e89 - e89. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |